Cherry Lim
Impact in
- Applied Microbiology and Biotechnology top 0.02%
- Antibiotic Use and Resistance
- Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 18
-
- Antibiotic Resistance in Bacteria 4
- Co-authors
- Direk Limmathurotsakul (13 shared papers)Nicholas Day (10 shared papers)Ben Symons Cooper (14 shared papers)Sharon J. Peacock (5 shared papers)Vanaporn Wuthiekanun (4 shared papers)Maliwan Hongsuwan (2 shared papers)Yin Mo (8 shared papers)Visanu Thamlikitkul (1 shared paper)
- Journals
- Wellcome Open Research (3 papers)Clinical Microbiology and Infection (3 papers)PLoS ONE (3 papers)The Lancet (2 papers)Nature Communications (2 papers)
- Partner nations
- ThailandUnited KingdomAustralia
In The Last Decade
Cherry Lim
31 papers receiving 13.9k citations
Cherry Lim's Hit Papers
Peers
Comparison fields: 5 of 167
- Applied Microbiology and Biotechnology 3.2k
- Molecular Medicine 3.2k
- Microbiology 757
- Pollution 1.1k
- Clinical Biochemistry 362
Countries citing papers authored by Cherry Lim
This map shows the geographic impact of Cherry Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cherry Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cherry Lim more than expected).
Fields of papers citing papers by Cherry Lim
This network shows the impact of papers produced by Cherry Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cherry Lim. The network helps show where Cherry Lim may publish in the future.
Co-authors
The 25 scholars most cited alongside Cherry Lim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis Hit paper breakdown → | 2022 | 11306 |
| 2 | Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 Hit paper breakdown → | 2024 | 1965 |
| 3 | 2016 | 239 | |
| 4 | 2017 | 156 | |
| 5 | 2015 | 62 | |
| 6 | 2020 | 58 | |
| 7 | 2021 | 57 | |
| 8 | 2015 | 46 | |
| 9 | 2016 | 43 | |
| 10 | 2013 | 38 | |
| 11 | 2023 | 37 | |
| 12 | 2016 | 30 | |
| 13 | 2023 | 28 | |
| 14 | 2020 | 27 | |
| 15 | 2020 | 26 | |
| 16 | 2017 | 21 | |
| 17 | 2015 | 19 | |
| 18 | 2021 | 16 | |
| 19 | 2021 | 15 | |
| 20 | 2020 | 12 |
About Cherry Lim
Cherry Lim is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Parasitology, Statistics and Probability and Epidemiology, having authored 34 papers that have together received 14.3k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (18 papers), Antibiotic Resistance in Bacteria (4 papers), Vector-borne infectious diseases (3 papers), Burkholderia infections and melioidosis (3 papers), Statistical Methods in Clinical Trials (3 papers), Infection Control in Healthcare (2 papers), Cervical Cancer and HPV Research (1 paper) and Data-Driven Disease Surveillance (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (3.2k citations), Molecular Medicine (3.2k citations), Microbiology (757 citations), Pollution (1.1k citations) and Clinical Biochemistry (362 citations). Cherry Lim has collaborated with scholars based in Thailand, United Kingdom and Australia. Frequent co-authors include Direk Limmathurotsakul, Nicholas Day, Ben Symons Cooper, Sharon J. Peacock, Vanaporn Wuthiekanun, Maliwan Hongsuwan, Yin Mo, Visanu Thamlikitkul, Soawapak Hinjoy and Pacharee Kantipong. Their work appears in journals such as Wellcome Open Research, Clinical Microbiology and Infection, PLoS ONE, The Lancet and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.